A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pergolide
Metiamide
Metiamide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Asenapine
Asenapine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Propacetamol
The serum concentration of Propacetamol can be increased when it is combined with Bosutinib.
Pergolide
Metreleptin
The metabolism of Bosutinib can be increased when combined with Metreleptin.
Pergolide
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Bosutinib.
Pergolide
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Bosutinib.
Pergolide
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Bosutinib.
Pergolide
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Bosutinib.
Pergolide
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Salvianolic acid A
Salvianolic acid A can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Dexlansoprazole
Bosutinib can cause a decrease in the absorption of Dexlansoprazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Aluminium phosphate
Aluminium phosphate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Calcium silicate
Calcium silicate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Aluminium glycinate
Aluminium glycinate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Almasilate
Almasilate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Magnesium peroxide
Magnesium peroxide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Aluminium acetoacetate
Aluminium acetoacetate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3